Lannett Receives FDA Approval for ANDA Supplement for Phentermine HCL Capsules, 15 mg
Lannett Company, Inc. today announced that it has received approval from the U.S. Food and Drug Administration of its supplemental Abbreviated New Drug Application for Phentermine HCl Capsules, 15 mg.

Lannett Receives FDA Approval for Hydrochlorothiazide Capsules, 12.5 mg
Lannett Company, Inc. today announced it has received approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application for Hydrochlorothiazide Capsules, 12.5 mg.

NPS Pharmaceuticals Announces FDA Acceptance of New Drug Application for GATTEX (teduglutide) for the Treatment of ...
NPS Pharmaceuticals, Inc. , a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today announced the U.S.